Get started
Author

Andreas G. Schätzlein

Observed names: A G Schatzlein, A G Schätzlein, A SCHATZLEIN, A Schatzlein, A. G. Schätzlein, A. Schaetzlein, A. Schatzlein, A. Schätzlein, A.G Schätzlein, A.G. Schatzlein, A.G. Schätzlein, AG Schaetzlein, Andreas G. Schätzlein, Andreas G Schätzlein, Andreas G. Schatzlein, Andreas G. Schätzlein, Andreas G. Schätzlein (2641360), Andreas G. Schätzleinä, Andreas Schatzlein, Andreas Schätzlein, Andreas Schätzlein, Andreas. G. Schatzlein, G. Schatzlein, A, Schaetzlein, AG, Schatzlein, A, Schatzlein, AG, SchÄtzlein, Schätzlein AG, Schätzlein, A.G., Schätzlein, AG, Schätzlein, Andreas 1963-, Schätzlein, Andreas G.
Observed institutions: AstraZeneca (United Kingdom), University of London, Institute of Cancer Research, University of Strathclyde, Universidade de Santiago de Compostela, Cancer Research UK, St James's University Hospital, Hammersmith Hospital, TUM Klinikum, Institute of Cancer Research, Cancer Research UK Scotland Institute, IDEA (Germany), St Mark's Hospital, Nanomerics Ltd. (United Kingdom), UCL School of Pharmacy, University College London, Imperial College London, Technical University of Munich, University of Glasgow, Damascus University
ORCID: 0000-0003-3907-6603
Observed ORCID: 0000-0003-3907-6603
OpenAlex ID: A5002296010
Dendrimers in gene delivery
2005 · C DUFES, I UCHEGBU, et al. · Advanced Drug Delivery Reviews · 986
Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin
1998 · Gregor Cevc, Dieter Gebauer, et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 478
Gene delivery with synthetic (non viral) carriers
2001 · Maureen D. Brown, Andreas G. Schätzlein, et al. · International Journal of Pharmaceutics · 367
Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements
2002 · Gregor Cevc, Andreas Schätzlein, et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 340
PDF
The Lower-Generation Polypropylenimine Dendrimers Are Effective Gene-Transfer Agents
2002 · Bernd H. Zinselmeyer, Simon P. Mackay, et al. · Pharmaceutical Research · 312
Transdermal drug carriers: Basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides
1995 · Gregor Cevc, Andreas Schätzlein, et al. · Journal of Controlled Release · 271
Nose-to-Brain Delivery
2019 · Zian Wang, Guojun Xiong, et al. · Journal of Pharmacology and Experimental Therapeutics · 242
PDF
The skin: a pathway for systemic treatment with patches and lipid-based agent carriers
1996 · Gregor Cevc, Gabriele Blume, et al. · Advanced Drug Delivery Reviews · 233
Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors
2007 · Kim Appleton, Helen J. Mackay, et al. · Journal of Clinical Oncology · 228
PDF
Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes)
1998 · SchÄtzlein, Cevc · British Journal of Dermatology · 193
Non-viral vectors in cancer gene therapy: principles and progress
2001 · A G Schatzlein · Anti-Cancer Drugs · 188
Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo1Dedicated to the late Dr. Henri Ernest Bodde.1
1997 · Gregor Cevc, Gabriele Blume, et al. · Journal of Controlled Release · 178
Amphiphilic poly(l-amino acids) — New materials for drug delivery
2012 · Aikaterini Lalatsa, Andreas G. Schätzlein, et al. · Journal of Controlled Release · 163
Strategies To Deliver Peptide Drugs to the Brain
2014 · Aikaterini Lalatsa, Andreas G. Schatzlein, et al. · Molecular Pharmaceutics · 161
Preliminary Characterization of Novel Amino Acid Based Polymeric Vesicles as Gene and Drug Delivery Agents
2000 · M. D. Brown, A. Schätzlein, et al. · Bioconjugate Chemistry · 143
Synthetic Anticancer Gene Medicine Exploits Intrinsic Antitumor Activity of Cationic Vector to Cure Established Tumors
2005 · Christine Dufès, W. Nicol Keith, et al. · Cancer Research · 142
PDF
Tumour vasculature as a target for anticancer therapy
2000 · M.M. Eatock, A. Schätzlein, et al. · Cancer Treatment Reviews · 139
Polymeric Chitosan-based Vesicles for Drug Delivery
1998 · Ijeoma F Uchegbu, Andreas G Schätzlein, et al. · Journal of Pharmacy and Pharmacology · 137
Preferential liver gene expression with polypropylenimine dendrimers
2004 · Andreas G. Schatzlein, Bernd H. Zinselmeyer, et al. · Journal of Controlled Release · 133
PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility
2004 · A Brownlie, I.F Uchegbu, et al. · International Journal of Pharmaceutics · 131
Enhanced Oral Absorption of Hydrophobic and Hydrophilic Drugs Using Quaternary Ammonium Palmitoyl Glycol Chitosan Nanoparticles
2011 · Adeline Siew, Hang Le, et al. · Molecular Pharmaceutics · 121
Carbohydrate-Based Micelle Clusters Which Enhance Hydrophobic Drug Bioavailability by Up to 1 Order of Magnitude
2006 · Xioazhong Qu, Vitaliy V. Khutoryanskiy, et al. · Biomacromolecules · 121
Niosomes and Polymeric Chitosan Based Vesicles Bearing Transferrin and Glucose Ligands for Drug Targeting
2000 · Christine Dufes, Andreas G. Schätzlein, et al. · Pharmaceutical Research · 116
PDF
Oral Particle Uptake and Organ Targeting Drives the Activity of Amphotericin B Nanoparticles
2015 · Dolores R. Serrano, Aikaterini Lalatsa, et al. · Molecular Pharmaceutics · 112
PDF
Anticancer Drug Delivery with Transferrin Targeted Polymeric Chitosan Vesicles
2004 · Christine Dufes, Jean-Marc Muller, et al. · Pharmaceutical Research · 112
PDF
Works count: 267
Citation count: 8,594
H-index: 46
I10-index: 89
Year
Topic
Type